Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Catheter Precision, Inc.

Catheter Precision, Inc. (VTAK) Stock Overview

Explore Catheter Precision, Inc.’s financial performance, market position, analyst ratings, and future outlook.

VTAK●AMEX
HealthcareMedical - Devices
$0.15
$0.001(0.66%)
U.S. Market opens in 29h 18m

Catheter Precision, Inc. (VTAK)

Meyka AI Score

Z

Key Financials

Market Cap317.4K
P/E Ratio-0.02
EPS (TTM)$-8.78
ROE-1.24%
Fundamental Analysis

AI Price Forecasts

1 Month$1.11
3 Months$0.00
1 Year Target$0.00

VTAK Stock Analysis & Investment Overview (AMEX)

Our AI-powered analysis of Catheter Precision, Inc. (AMEX: VTAK) gives investors deep insight into how the stock performs on the AMEX exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Catheter Precision, Inc.'s AMEX-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of VTAK on the AMEX shows an RSI of 58.30, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $0.00 for the AMEX listing.

Key metrics behind Catheter Precision, Inc.'s AMEX-traded stock include a P/E ratio of -0.02 and a market capitalization of 317.4K. Combined with our AI analysis, these give both institutional and retail investors a clear view of VTAK on the AMEX.

Price Performance (AMEX: VTAK)

1-Day Change
N/A
5-Day Change
-84.59%
1-Month Change
-90.50%
3-Month Change
-96.29%
6-Month Change
-98.40%
Year-to-Date (YTD) Change
-99.17%
1-Year Change
-99.44%
3-Year Change
-99.98%
5-Year Change
-100.00%
All-Time (Max) Change
-100.00%

Contact Information

https://www.catheterprecision.com
973 691 2000
1670 Highway 160 West, Fort Mill, SC, 29708

Company Facts

170 Employees
IPO DateSep 27, 2018
CountryUS

Frequently Asked Questions